Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
600105 Jiangsu Etern
- 6.30
- -0.02-0.32%
Not Open Apr 24 15:00 CST
9.21BMarket Cap28.38P/E (TTM)
6.58High6.24Low1.89MlotVolume6.30Open6.32Pre Close1.21BTurnover12.94%Turnover Ratio150.00P/E (Static)1.46BShares7.4552wk High2.73P/B9.21BFloat Cap3.3152wk Low6.95Limit Up1.46BShs Float16.29Historical High5.69Limit Down5.38%Amplitude0.11Historical Low0.04Dividend TTM6.37Avg Price956.95KlotAsk0.57%Div YieldTTM100Lot Size892.20KlotBid
Jiangsu Etern Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 7.54%877.75M | -5.38%4.11B | 0.92%2.97B | -2.92%1.82B | -12.75%816.24M | 2.78%4.35B | -4.68%2.95B | 1.90%1.88B | 1.21%935.49M | 8.13%4.23B |
| Operating revenue | 7.54%877.75M | -5.38%4.11B | 0.92%2.97B | -2.92%1.82B | -12.75%816.24M | 2.78%4.35B | -4.68%2.95B | 1.90%1.88B | 1.21%935.49M | 8.13%4.23B |
| Other operating revenue | ---- | 1.47%104.07M | ---- | -29.67%37.04M | ---- | --102.57M | ---- | 48.89%52.66M | ---- | ---- |
| Total operating cost | 8.70%894.62M | -3.73%4.1B | -1.21%2.9B | -4.76%1.8B | -13.07%823M | 0.57%4.26B | -4.21%2.93B | 2.56%1.89B | 1.21%946.69M | 4.83%4.23B |
| Operating cost | 11.02%749.19M | -4.58%3.43B | -1.07%2.44B | -6.48%1.5B | -14.32%674.82M | -1.88%3.59B | -8.95%2.47B | 0.06%1.6B | 0.61%787.62M | 4.04%3.66B |
| Operating tax surcharges | 58.83%6.19M | -6.55%19.39M | -14.55%13.1M | -22.37%7.77M | -22.43%3.9M | -2.24%20.75M | -1.64%15.34M | 0.70%10M | 14.95%5.03M | 140.88%21.22M |
| Operating expense | 8.08%19.99M | 17.95%81.32M | 10.26%58.9M | 14.97%38.78M | 10.63%18.5M | 6.53%68.94M | 14.64%53.42M | 20.07%33.73M | -30.96%16.72M | -10.14%64.72M |
| Administration expense | 12.46%56.99M | 17.37%265.55M | -1.87%161.29M | 2.54%109.64M | -8.33%50.68M | -5.18%226.25M | 8.17%164.37M | -0.71%106.92M | -14.46%55.29M | 20.18%238.62M |
| Financial expense | -52.61%12.45M | -39.29%64.4M | -16.66%69.79M | -6.40%37.45M | -25.23%26.26M | 71.34%106.08M | 198.20%83.74M | 40.37%40.01M | 21.28%35.13M | -25.25%61.91M |
| -Interest expense (Financial expense) | -5.86%21.44M | -4.18%100.92M | -2.87%79.03M | -4.26%52.2M | -20.81%22.78M | 35.83%105.32M | 22.07%81.37M | 22.22%54.53M | 39.29%28.77M | 29.13%77.54M |
| -Interest Income (Financial expense) | -164.39%-7.72M | -31.69%-38.25M | -248.44%-27.54M | -171.88%-18.48M | 19.60%-2.92M | -80.90%-29.05M | 17.83%-7.9M | 15.61%-6.8M | -71.94%-3.63M | -93.47%-16.06M |
| Research and development | 1.99%49.81M | -1.19%239.15M | 3.08%157.06M | 10.72%109.89M | 4.13%48.84M | 31.15%242.01M | 33.95%152.37M | 42.66%99.25M | 54.34%46.9M | 18.38%184.53M |
| Credit Impairment Loss | -37.37%680.74K | 53.63%-40.1M | -203.17%-7.86M | -96.04%429.37K | -81.39%1.09M | -102.85%-86.48M | 181.93%7.62M | 288.65%10.83M | 158.13%5.84M | -31.25%-42.63M |
| Asset Impairment Loss | -279.12%-3.09M | -388.90%-57.92M | 90.34%-543K | -49.88%1.02M | 183.98%1.73M | 62.96%-11.85M | -321.10%-5.62M | 2.97%2.05M | -394.98%-2.05M | -1.95%-31.98M |
| Other net revenue | 601.98%308.38M | 192.96%85.39M | -47.09%52.57M | -26.88%51.41M | -3.64%43.93M | -86.05%29.15M | 23.38%99.35M | 25.81%70.31M | 40.54%45.59M | -21.29%208.98M |
| Fair value change income | -108.50%-56.11K | -1,116.81%-4.48M | 10.95%880.56K | 315.04%1.56M | -25.16%660.25K | -82.34%440.87K | 659.70%793.67K | -77.11%376.62K | -51.68%882.19K | 309.19%2.5M |
| Invest income | 1,093.81%304.7M | 125.63%137.17M | -55.96%26.13M | -44.73%23.38M | -17.83%25.52M | -72.69%60.79M | 13.64%59.34M | 8.87%42.3M | 15.17%31.06M | -18.17%222.63M |
| -Including: Investment income associates | 1,094.37%303.38M | 125.53%135.51M | -56.73%25.2M | -44.37%23.43M | -16.38%25.4M | -33.67%60.09M | 14.79%58.24M | 16.74%42.12M | 25.90%30.38M | -35.41%90.59M |
| Asset deal income | ---- | -132.64%-2.93M | -147.50%-3.01M | -165.25%-3.01M | -98.36%74.04K | -27.72%8.99M | -48.99%6.33M | -9.65%4.61M | -11.58%4.52M | --12.43M |
| Other revenue | -58.65%6.15M | -6.28%53.66M | 19.68%36.97M | 176.12%28.02M | 178.39%14.86M | 24.37%57.25M | 37.03%30.89M | -27.74%10.15M | -32.28%5.34M | -21.28%46.03M |
| Operating profit | 684.32%291.5M | -16.02%98.07M | 14.24%126.31M | 29.53%72.12M | 8.07%37.17M | -42.59%116.79M | 3.17%110.57M | 4.31%55.68M | 61.42%34.39M | 48.26%203.42M |
| Add:Non operating Income | 86.44%160.48K | 74.51%2.43M | 112.97%2.06M | 156.92%1.94M | -76.95%86.07K | -21.91%1.39M | -37.94%969.29K | -44.37%756.45K | -56.85%373.37K | -75.28%1.79M |
| Less:Non operating expense | -5.45%2.88M | 32.07%3.73M | 110.33%3.54M | 453.32%3.08M | 627.31%3.04M | -51.68%2.83M | -6.36%1.68M | -67.10%556.57K | -63.24%418.61K | 8.63%5.85M |
| Total profit | 744.20%288.79M | -16.11%96.77M | 13.64%124.83M | 27.03%70.98M | -0.40%34.21M | -42.14%115.35M | 2.73%109.85M | 5.34%55.88M | 63.30%34.35M | 43.38%199.36M |
| Less:Income tax cost | 32.09%3.21M | 1,505.43%24.62M | 92.91%21.19M | 54.66%12.2M | -46.26%2.43M | 105.43%1.53M | -9.69%10.98M | -19.78%7.89M | 45.98%4.53M | -277.52%-28.23M |
| Net profit | 798.74%285.57M | -36.61%72.15M | 4.83%103.65M | 22.49%58.78M | 6.56%31.77M | -49.99%113.82M | 4.32%98.87M | 11.06%47.99M | 66.30%29.82M | 55.33%227.59M |
| Net profit from continuing operation | 798.74%285.57M | -36.61%72.15M | 4.83%103.65M | 22.49%58.78M | 6.56%31.77M | -49.99%113.82M | 4.32%98.87M | 11.06%47.99M | 66.30%29.82M | 55.33%227.59M |
| Less:Minority Profit | -194.39%-4.2M | -84.79%10.73M | 290.51%46.34M | 254.10%27.48M | -21.45%4.45M | 431.85%70.57M | -10.95%11.87M | -39.46%7.76M | 58.78%5.67M | -48.70%13.27M |
| Net profit of parent company owners | 960.55%289.77M | 42.00%61.41M | -34.14%57.3M | -22.19%31.3M | 13.14%27.32M | -79.82%43.25M | 6.82%87M | 32.38%40.23M | 68.17%24.15M | 77.63%214.32M |
| Earning per share | ||||||||||
| Basic earning per share | 916.41%0.1982 | 33.33%0.04 | -33.87%0.041 | -24.14%0.022 | 13.37%0.0195 | -80.00%0.03 | 6.90%0.062 | 31.82%0.029 | 68.63%0.0172 | 66.67%0.15 |
| Diluted earning per share | 916.41%0.1982 | 33.33%0.04 | -33.87%0.041 | -24.14%0.022 | 13.37%0.0195 | -80.00%0.03 | 6.90%0.062 | 31.82%0.029 | 68.63%0.0172 | 66.67%0.15 |
| Other composite income | -3,016.49%-4.4M | -68.55%1.24M | 18.00%-874.94K | -51.26%544.84K | 104.95%150.84K | 19.20%3.95M | -113.99%-1.07M | -67.12%1.12M | -1,015.66%-3.05M | 209.36%3.32M |
| Other composite income of parent company owners | -2,693.67%-2.26M | -79.62%683.62K | -3,217.11%-471.68K | 260.46%313.86K | 103.38%87.25K | 202.35%3.36M | -99.68%15.13K | -107.94%-195.6K | -1,805.56%-2.58M | 170.78%1.11M |
| Other composite income of minority owners | -3,459.38%-2.14M | -6.51%560.09K | 62.73%-403.26K | -82.42%230.98K | 113.61%63.59K | -72.86%599.11K | -137.44%-1.08M | 40.14%1.31M | -239.12%-467.28K | 250.63%2.21M |
| Total composite income | 780.71%281.17M | -37.68%73.39M | 5.08%102.77M | 20.81%59.33M | 19.26%31.93M | -48.99%117.77M | -4.49%97.8M | 5.36%49.11M | 51.61%26.77M | 60.92%230.9M |
| Total composite income of parent company owners | 948.92%287.51M | 33.24%62.1M | -34.69%56.83M | -21.03%31.61M | 27.08%27.41M | -78.37%46.61M | 0.97%87.02M | 21.86%40.03M | 51.62%21.57M | 80.90%215.43M |
| Total composite income of minority owners | -240.38%-6.34M | -84.13%11.29M | 325.95%45.94M | 205.39%27.71M | -13.17%4.52M | 359.86%71.17M | -33.49%10.79M | -34.04%9.08M | 51.54%5.2M | -36.57%15.48M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs